comparemela.com

Latest Breaking News On - Emmanuel papadakis - Page 7 : comparemela.com

GSK : Deutsche Bank maintains a Buy rating -December 15, 2023 at 07:17 am EST

Emmanuel Papadakis from Deutsche Bank retains his positive opinion on the stock with a Buy rating. The target price remains set at GBX 1700.

NOVO NORDISK : Receives a Buy rating from Deutsche Bank -December 08, 2023 at 06:13 am EST

Already positive, the research from Deutsche Bank and its analyst Emmanuel Papadakis still consider the stock as a Buy opportunity. The target price is unchanged and still at DKK 775.

GSK : Deutsche Bank reaffirms its Buy rating -December 01, 2023 at 06:01 am EST

Analyst Emmanuel Papadakis from Deutsche Bank research considers the stock attractive and recommends it with a Buy rating. The target price continues to be set at GBX 1700.

GSK : Receives a Buy rating from Deutsche Bank -November 28, 2023 at 03:06 am EST

Emmanuel Papadakis from Deutsche Bank retains his positive opinion on the stock with a Buy rating. The target price continues to be set at GBX 1700.

NOVARTIS AG : Receives a Buy rating from Deutsche Bank -November 27, 2023 at 05:46 am EST

Emmanuel Papadakis from Deutsche Bank retains his positive opinion on the stock with a Buy rating. The target price is unchanged at CHF 110.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.